Model DetailsLung tumor
Model Name |
Lung tumor | Strain |
A/J |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
pulmonary tumor • lung tumor |
Strain Synonyms |
A • A/J-Jax • Strain A • A/J, H-2a • A/Lilly • A/Jax • AJ • strain A • A/Cloudman |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Male |
0% (0 of 10 mice) |
2 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 10 mice) |
3 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
4 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
5 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
0% (0 of 20 mice) |
6 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
5% (1 of 20 mice) |
7 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
12% (4 of 34 mice) |
8 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
18% (8 of 44 mice) |
9 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
44% (17 of 39 mice) |
10 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
40% (22 of 55 mice) |
11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
39% (27 of 70 mice) |
12 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
57% (29 of 51 mice) |
13 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
43% (33 of 76 mice) |
14 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
59% (29 of 49 mice) |
15 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
67% (29 of 43 mice) |
16 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
62.5% (20 of 32 mice) |
17 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
73% (36 of 49 mice) |
18 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
81% (38 of 47 mice) |
19 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
78% (18 of 23 mice) |
20 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
37% (58 of 157 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
43% (74 of 173 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Male |
36% (20 of 55 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 10 mice) |
2 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 10 mice) |
3 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
4.8% (1 of 21 mice) |
4 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
0% (0 of 20 mice) |
5 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
5% (1 of 20 mice) |
6 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
5% (1 of 20 mice) |
7 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
7.3% (3 of 41 mice) |
8 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
21% (7 of 34 mice) |
9 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
23% (29 of 128 mice) |
10 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
37% (19 of 51 mice) |
11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
36% (27 of 76 mice) |
12 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
40% (21 of 53 mice) |
13 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
45% (25 of 56 mice) |
14 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
53% (27 of 51 mice) |
15 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
61% (11 of 18 mice) |
17 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
65% (24 of 37 mice) |
18 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
67% (12 of 18 mice) |
19 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
75% (15 of 20 mice) |
20 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
27% (49 of 182 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
32% (50 of 157 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Female |
32% (17 of 53 mice) |
10-11 months |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |